Brain-gut interactions: Implications for newer therapy

European Journal of Surgery, Supplement

Volumn 164, Issue 582, 1998, Pages 50-55

  Mayer, Emeran A ^a,b   Chang, Lin ^a   Lembo, Tony ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Irritable bowel syndrome; Treatment

Indexed keywords

ANTIDIARRHEAL AGENT; ANXIOLYTIC AGENT; ATROPINE PLUS DIPHENOXYLATE; CISAPRIDE; CODEINE; GASTROINTESTINAL AGENT; LOPERAMIDE; MUSCARINIC M3 RECEPTOR ANTAGONIST; OCTREOTIDE; PLACEBO; PROKINETIC AGENT; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ARTICLE; BRAIN; DIETARY FIBER; DIGESTIVE SYSTEM FUNCTION DISORDER; HUMAN; IRRITABLE COLON; MENTAL STRESS; ORAL DRUG ADMINISTRATION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION; DIGESTIVE SYSTEM; MENTAL DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

BRAIN; COLONIC DISEASES, FUNCTIONAL; DIGESTIVE SYSTEM; HUMANS; MENTAL DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 0032216787     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994; 39: 2352-2363.
2. 2. Houghton LA, Jackson NA, Whorwell PJ, et al. 5HT4 Antagonism in irritable bowel syndrome (IBS): Effect of SB-207266-A on rectal sensitivity and small bowel transit. [Abstract] Gut 1997; 41 (Suppl 3): A26.
3. 3. Hurlimann S, Shorvon P, Misiewicz JJ. Effects of cisapride on symptoms and ileo-caecal transit in patients with bloated bowel syndrome, [Abstract] Gastroenterology 1992; 102: 460.
4. 4. Klein KB. Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 1988; 95: 232-241.
5. 5. Lavo B, Stenstam M, Nielsen AL. Loperamide in treatment of irritable bowel syndrome-a double blind placebo controlled study. Scand J Gastroenterol Suppl 1987; 130: 77-80.
6. 6. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-293.
7. 7. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer E. Altered rectal perception is a biological marker of patients with the irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
8. 8. Muller-Lissner SA. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J Clin Res Ed 1988; 296 (6622): 615-617.
9. 9. Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable syndrome. Gastroenterology 1997; 112: 55-63.
10. 10. Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-512.
11. 11. Poynard T, Naveau S, Mory B, Chaput JC. Metaanalysis of smoooth muscle relaxants in the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 1994; 8: 499-510.
12. 12. Quigley EMM. Intestinal manometry-technical advances, clinical limitations. Dig Dis Sci 1992; 37: 10-13.
13. 13. Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997; 112: 64-72.
14. 14. Sperling RM, McQuaid KR. Rational medical therapy of functional GI disorders. In: Sperling RM, McQuaid KR, Olden KW, eds. Handbook of functional gastrointestinal disorders. New York: Marcel Dekker, Inc.; 1996; 13: 269-328.
15. 15. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996; 91: 277-283.
16. 16. Van Outryve M, Milo R, Toussaint J, Van Eeghem P. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991; 13: 49-57.
17. 17. Whitehead WE, Bosmajian L, Zonderman AB, Costa Jr PT, Schuster MM. Symptoms of psychological distress associated with irritable bowel syndrome. Gastroenterology 1988; 95: 709-714.